Ankyrin-B syndrome

Enhanced cardiac function balance by risk of cardiac death and premature senescence

Peter J. Mohler, Jane A. Healy, Hui Xue, Annibale A. Puca, Crystal F. Kline, R. Rand Allingham, Evangelia G. Kranias, Howard A. Rockman, Vann Bennett

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

Here we report the unexpected finding that specific human ANK2 variants represent a new example of balanced human variants. The prevalence of certain ANK2 (encodes ankyrin-B) variants range from 2 percent of European individuals to 8 percent in individuals from West Africa. Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. Variants associated with less severe clinical and in vitro phenotypes were unexpectedly common. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term "ankyrin-B syndrome", which may contribute to both aging-related disorders and enhanced cardiac function.

Original languageEnglish
Article numbere1051
JournalPLoS One
Volume2
Issue number10
DOIs
Publication statusPublished - Oct 17 2007

Fingerprint

Ankyrins
ankyrins
cardiac output
death
Phenotype
Western Africa
phenotype
Cardiac Arrhythmias
arrhythmia
Costs and Cost Analysis
Aging of materials
Population
Ankyrin-B-Related Cardiac Arrhythmia
mice
Costs

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Mohler, P. J., Healy, J. A., Xue, H., Puca, A. A., Kline, C. F., Allingham, R. R., ... Bennett, V. (2007). Ankyrin-B syndrome: Enhanced cardiac function balance by risk of cardiac death and premature senescence. PLoS One, 2(10), [e1051]. https://doi.org/10.1371/journal.pone.0001051

Ankyrin-B syndrome : Enhanced cardiac function balance by risk of cardiac death and premature senescence. / Mohler, Peter J.; Healy, Jane A.; Xue, Hui; Puca, Annibale A.; Kline, Crystal F.; Allingham, R. Rand; Kranias, Evangelia G.; Rockman, Howard A.; Bennett, Vann.

In: PLoS One, Vol. 2, No. 10, e1051, 17.10.2007.

Research output: Contribution to journalArticle

Mohler, PJ, Healy, JA, Xue, H, Puca, AA, Kline, CF, Allingham, RR, Kranias, EG, Rockman, HA & Bennett, V 2007, 'Ankyrin-B syndrome: Enhanced cardiac function balance by risk of cardiac death and premature senescence', PLoS One, vol. 2, no. 10, e1051. https://doi.org/10.1371/journal.pone.0001051
Mohler, Peter J. ; Healy, Jane A. ; Xue, Hui ; Puca, Annibale A. ; Kline, Crystal F. ; Allingham, R. Rand ; Kranias, Evangelia G. ; Rockman, Howard A. ; Bennett, Vann. / Ankyrin-B syndrome : Enhanced cardiac function balance by risk of cardiac death and premature senescence. In: PLoS One. 2007 ; Vol. 2, No. 10.
@article{1b46cff72bfc4545aa86659ad33fc342,
title = "Ankyrin-B syndrome: Enhanced cardiac function balance by risk of cardiac death and premature senescence",
abstract = "Here we report the unexpected finding that specific human ANK2 variants represent a new example of balanced human variants. The prevalence of certain ANK2 (encodes ankyrin-B) variants range from 2 percent of European individuals to 8 percent in individuals from West Africa. Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. Variants associated with less severe clinical and in vitro phenotypes were unexpectedly common. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term {"}ankyrin-B syndrome{"}, which may contribute to both aging-related disorders and enhanced cardiac function.",
author = "Mohler, {Peter J.} and Healy, {Jane A.} and Hui Xue and Puca, {Annibale A.} and Kline, {Crystal F.} and Allingham, {R. Rand} and Kranias, {Evangelia G.} and Rockman, {Howard A.} and Vann Bennett",
year = "2007",
month = "10",
day = "17",
doi = "10.1371/journal.pone.0001051",
language = "English",
volume = "2",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "10",

}

TY - JOUR

T1 - Ankyrin-B syndrome

T2 - Enhanced cardiac function balance by risk of cardiac death and premature senescence

AU - Mohler, Peter J.

AU - Healy, Jane A.

AU - Xue, Hui

AU - Puca, Annibale A.

AU - Kline, Crystal F.

AU - Allingham, R. Rand

AU - Kranias, Evangelia G.

AU - Rockman, Howard A.

AU - Bennett, Vann

PY - 2007/10/17

Y1 - 2007/10/17

N2 - Here we report the unexpected finding that specific human ANK2 variants represent a new example of balanced human variants. The prevalence of certain ANK2 (encodes ankyrin-B) variants range from 2 percent of European individuals to 8 percent in individuals from West Africa. Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. Variants associated with less severe clinical and in vitro phenotypes were unexpectedly common. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term "ankyrin-B syndrome", which may contribute to both aging-related disorders and enhanced cardiac function.

AB - Here we report the unexpected finding that specific human ANK2 variants represent a new example of balanced human variants. The prevalence of certain ANK2 (encodes ankyrin-B) variants range from 2 percent of European individuals to 8 percent in individuals from West Africa. Ankyrin-B variants associated with severe human arrhythmia phenotypes (eg E1425G, V1516D, R1788W) were rare in the general population. Variants associated with less severe clinical and in vitro phenotypes were unexpectedly common. Studies with the ankyrin-B+/- mouse reveal both benefits of enhanced cardiac contractility, as well as costs in earlier senescence and reduced lifespan. Together these findings suggest a constellation of traits that we term "ankyrin-B syndrome", which may contribute to both aging-related disorders and enhanced cardiac function.

UR - http://www.scopus.com/inward/record.url?scp=38049084008&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=38049084008&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0001051

DO - 10.1371/journal.pone.0001051

M3 - Article

VL - 2

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 10

M1 - e1051

ER -